Challenges and Emerging Technologies in Biomanufacturing of Monoclonal Antibodies (mAbs)
Therapeutic antibodies dominate the biopharmaceutical market with continual innovations being made to provide novel and improved antibody treatment strategies. Speed to-market and cost-efficiency are of increasing importance due to the changing landscape of the biopharmaceutical industry. The increa...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84864 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Challenges and Emerging Technologies in Biomanufacturing of Monoclonal Antibodies (mAbs)
- Emerging Monoclonal Antibodies for the Treatment of Multiple Myeloma
- Introduction on Monoclonal Antibodies
- The Emerging Role of Monoclonal Antibodies in the Treatmentof Systemic Lupus Erythematosus
- Monoclonal Antibodies for Cancer Treatment
- Biosimilar Monoclonal Antibodies in Latin America
- Dynamic Optimization for Monoclonal Antibody Production